Evidentiary Hearing for “Cross Cutting” Ozempic Lawsuit Causation Issues Scheduled for May 2025
The extensive pretrial proceedings mean the first Ozempic bellwether trials are unlikely to begin until at least 2026 or 2027.
The extensive pretrial proceedings mean the first Ozempic bellwether trials are unlikely to begin until at least 2026 or 2027.
The Court may soon allow future lawsuits over Ozempic, Wegovy, Mounjaro and other GLP-1s to be brought using a Short Form Complaint, adopting allegations from the MDL Master Complaint.
Inadequate bowel prep due to side effects of Ozempic and Mounjaro carries significant risk of missed lesions, canceled procedures and other complications.
Awareness of Ozempic and Wegovy side effects may be driving more younger patients to report adverse events linked to the drugs, researchers speculate.
A combination of both GLP-1 medications and exercise were needed to achieve weight loss without also losing bone density, researchers found.
The FDA has received more than 200 reports of suicide or suicidal ideations linked to widely used diabetes and weight loss drugs like Ozempic, Wegovy, Mounjaro and Zepbound.
The cost of Ozempic, Wegovy and other similar diet drugs often exceeded most people's "willingness-to-pay" price point for the weight loss benefits they provided, researchers noted.
The findings add pancreatitis to the growing list of side effects of Ozempic, Wegovy and similar drugs being frequently used for weight loss, which have already been linked to reports of gastroparesis and bowel blockages
Previous studies involving similar diabetes drugs suggest Ozempic and Wegovy side effects may delay food passing through the stomach, which could lead to excessive vomiting and other health risks.
Higher doses and longer durations of use both appeared to increase the gallbladder risks, researchers warn.